TGM2 Antibody

1. Data suggest that disulfide bond switch in allosteric activation/inactivation of TGM2 is example of post-translational redox regulation that is reversibly and allosterically modulated by two proteins (ERp57 and TRX). (TGM2 = transglutaminase 2; ERp57 = endoplasmic reticulum resident protein 57; TRX = thioredoxin-1) PMID: 29305423
2. This suggests that TGase 2 has an allosteric binding site (81-116 a.a) which changes the conformation of TGase 2 enough to accelerate inactivation through self-polymer formation. PMID: 30105541
3. Taken together, the present data suggested a potentially important role for TGM2 in the regulation of osteosarcoma chemosensitivity. TGM2 might therefore serve as a therapeutic target for osteosarcoma. PMID: 30015899
4. Multiple symptoms and high serum anti-tTG antibody levels correlated with mucosal damage in children with Celiac disease. PMID: 30016777
5. Production of anti-TG2 antibodies could be due to a general state of inflammation or could indicate a very early stage of a gluten-dependent pathology. PMID: 28934109
6. A long non-coding RNA is located within the first intron of transglutaminase 2 gene. LOC107987281 lncRNA is induced when levels of TGM2 transcripts are also increased, for example after drug treatment. In addition, correlation analysis between the expression of this lncRNA and TGM2 demonstrated that occurs in relation to the development of several tumors affecting pancreas, stomach and kidney. PMID: 29313085
7. TG2 plays a crucial role in the proliferative process PMID: 27591334
8. The results point to regulation of alternative splicing of tissue transglutaminase could account for the complex physiopathology of celiac disease. PMID: 29543397
9. Our data revealed that patients with lower level of TG2 expression detected in cancer tissues had longer disease free survival and overall survival as compared to the patients with higher TG2 expression. PMID: 28715877
10. Gluten-free diet compliance and lower antitissue transglutaminase (atTG) at diagnosis are predictors of earlier normalization of atTG levels in patients with celiac disease. Patients with type 1 diabetes mellitus are less likely to normalize atTG levels, with longer normalization time. PMID: 27906802
11. expression in psoriasis was higher than in normal skin PMID: 28150335
12. Serum tissue transglutaminase antibody was elevated in almost one-quarter of an eosinophilic esophagitis (EoE) cohort, and at least 20% of these patients did not have potential celiac disease, suggesting EoE is a heterogeneous disease with differing immune mechanisms activated in some patients. PMID: 28644352
13. Study indicates that TGM2 affects the metastatic potential and stemness of colorectal cancer stem cells by regulating EMT- and stemness-related proteins. PMID: 29374703
14. PARP3 controls of TGFbeta-induced epithelial mesenchymal transformation and acquisition of stem-like cell features by stimulation transglutaminase 2/SNAI1 signaling. PMID: 27579892
15. Circulating tissue transglutaminase is associated with sFlt-1, soluble endoglin and VEGF in the maternal circulation of preeclampsia patients, suggesting that tTG may have a role in the pathogenesis of PE. PMID: 27169826
16. 19% of pediatric celiac disease patients treated with a gluten-free diet had persistent enteropathy. At the time of the repeat biopsy, tTG was elevated in 43% of cases with persistent enteropathy and 32% of cases in which there was mucosal recovery. Overall the positive predictive value of the autoantibody tTG was 25% and the negative predictive value was 83% in patients on a gluten-free diet for a median of 2.4 years. PMID: 28112686
17. Computational analyses of the effect of novel amino acid clusters of human transglutaminase 2 on its structure and function have been presented. PMID: 27627884
18. The link is being discussed between P2X7R signaling and TG2 export, a pathway that has been recently discovered and tied extracellular protein modifications into the danger signal-mediated innate immune response. (Review) PMID: 27562793
19. TG2-regulated signaling bestows on cancer cells the ability to proliferate, to resist cell death, to invade, to reprogram glucose metabolism and to metastasize, making it a therapeutic target. (Review) PMID: 27562794
20. TGM2 is involved in the resistance of cancer cells to the histone deacetylase inhibitor vorinostat. PMID: 27761756
21. TGM2 is involved in amyloid-beta (1-42)-induced pro-inflammatory activation via AP1/JNK signaling pathways in cultured monocytes. PMID: 27864692
22. The role of TG2 in certain pathological conditions, in which inflammation and monocytes and/or macrophages are prominently present, including atherosclerosis, sepsis, and multiple sclerosis, has been discussed. (Review) PMID: 27659795
23. The 45 kDa gelatin-binding domain of fibronectin is responsible for the binding to TGM2. PMID: 27394141
24. Inter-molecular crosslinking activity is engendered by the dimeric form of transglutaminase 2. PMID: 27394142
25. Transglutaminase type 2 affects cell migration through post-translational modification of PDGF-BB. PMID: 27633721
26. An increased chondrocyte TGM2 expression characterized human osteoarthritis cartilage degeneration, but not trabecular bone tissue remodeling independently from the cause. PMID: 27357308
27. High TGM2 expression is associated with recurrence in Glioma. PMID: 28754668
28. Exosomes from cells lacking TG2 present less protein content. Proteasome inhibition leads to the selective recruitment of TG2 in the exosomes. TG2 is an important player in the biogenesis of exosomes controlling the selectivity of their cargo under stressful cellular conditions. PMID: 27169926
29. High transglutaminase 2 expression is associated with colorectal cancer. PMID: 28223538
30. GTP binding, but not transamidase activity, is required for TG2-dependent cancer stem cell invasion, migration and tumour formation. However, transamidase site-specific inhibitors reduce cancer stem cell survival. PMID: 27941875
31. these findings ascribe a novel function for ALDH1A3 in an aggressive glioma stem cells phenotype via the up-regulation of tissue transglutaminase PMID: 28423611
32. Data show that carboxyl-terminus of Hsp70-interacting protein (CHIP) promotes polyubiquitination of transglutaminase 2 (TG2) and its subsequent proteasomal degradation. PMID: 26568304
33. No clear evidence for an association of tTGA or EMA seropositivity with incident coronary heart disease outcomes, suggesting that tTG autoimmunity is unlikely to be the biological link between coeliac disease and CHD. PMID: 28756971
34. the TG2 enzymatic activity was negligibly affected by bexarotene treatment. It is important to control TG2 overexpression since its upregulation is correlated with tumor transformation and drug resistance. Bexarotene also showed in vivo tumoricidal effects in a GBM xenograft mouse model. Therefore, we suggest bexarotene as a more beneficial differentiation agent than ATRA for GBM. PMID: 26957434
35. Thus it can be concluded that human transglutaminases differ in harboring damaging variants and TGM2 is under purifying selection suggesting that it may have so far not revealed physiological functions. PMID: 28248968
36. mechanical load-induced TGM2 expression and enzyme activity is involved in the progression of the calcification of ligamentum flavum. PMID: 27115725
37. interconnected network of TG2/NF-kappaB and IL6/STAT3 signaling with autophagy regulation in MCL cells. PMID: 27488529
38. TGM2 expression was not significantly correlated with ovarian cancer antineoplastic drug resistance. PMID: 27669502
39. The serum level of TG2 is increased in patients with chronic spontaneous urticarial, and TG2 is expressed in mast cells in the lesional skin of these patients. PMID: 27613463
40. these findings suggest that constitutive TG2 expression results in stabilization of DeltaNp63alpha, leading to maintenance of epidermal squamous cell carcinoma cancer stem cell properties and enhanced tumor formation PMID: 27780825
41. TGM2 has a role in macrophage differentiation via mechanisms involving CD14 and SR-AI receptors. TGM2 inhibition triggers a pro-inflammatory phenotype. PMID: 27378395
42. The mRNA level of EMT-related genes was highly positively correlated with TGM2 mRNA. TGM2 might contribute to early hepatocellular carcinoma (HCC)recurrence through signaling pathways not related to EMT and integrin signaling PMID: 28339069
43. C-terminal truncation of transglutaminase 2 (TG2) reduces binding to the small intestinal extracellular matrix (ECM) despite retained fibronectin (FN)-binding capacity. PMID: 27685605
44. Ablation of transglutaminase 2 impairs astrocyte migration subsequent to injury. Astrocyte migration can only be restored with catalytically active transglutaminase 2. PMID: 27899316
45. findings support the potential pathophysiological relevance of TRX in celiac disease and establish the Cys(370)-Cys(371) disulfide bond of TG2 as one of clearest examples of an allosteric disulfide bond in mammals. PMID: 28003361
46. TG2 has another role in cystic fibrosis pathology linked with TGFbeta1 activation and signaling. PMID: 27234323
47. the ability of epitope 1-targeting B cells to keep TG2 active and protected from oxidation might explain why generation of epitope 1-targeting plasma cells seems to be favored in celiac patients. PMID: 27784785
48. TGM2 levels in sputum and plasma were elevated in patients with moderate to severe chronic obstructive pulmonary disease, and correlated with lung function. PMID: 27084846
49. our results demonstrate that TG2 secreted in the pancreatic TME orchestrates the cross talk between cancer cells and stroma, impacting tumor growth and response to chemotherapy. PMID: 27792935
50. TTG is an excellent screening test for the diagnosis of paediatric CD. TTG value > 50 IU/ml has 100% positive predictive value. PMID: 27097694

显示更多

收起更多

HGNC: 11778

OMIM: 190196

KEGG: hsa:7052

STRING: 9606.ENSP00000355330

UniGene: Hs.517033